Archive for the ‘VentureCapital’ Category

Kirenaga Invests in Violet Defense

Posted on: April 20th, 2020 by Kirenaga Partners

Kirenaga Partners is pleased to announce it completed a Series A investment in Violet Defense Group, a technology leader in providing ultraviolet lighting solutions for germ disinfection, as well as agricultural lighting solutions for indoor growing.  

Orlando-based Violet Defense utilizes its patented ultraviolet lighting technology to provide full-spectrum germ-killing.  Violet Defense’s Surface and Air Germ Elimination (S.A.G.E.) devices can be used in mobile deployments or permanently installed, and their products are currently used in operating rooms, hotels, schools, ambulances, food processing, and athletic facilities.  Violet Defense has previously announced collaborations with Siemens and the Orlando Magic, and most recently, is working with Koch Industries in a design collaboration to address PPE and mask issues associated with the COVID-19 crisis.

The investment, led by Kirenaga with participation from existing investor Northwestern University, comes at a time when demand for virus-killing solutions is increasing due to COVID-19.  Violet Defense has raised more than $10 million in venture funding, with the vast majority provided by Kirenaga.

Violet Defense expects to use the proceeds to expand its management team, invest in next generation products for both the domestic and international marketplace, and rapidly ramp up manufacturing capacity to meet increased customer demand.  

For more information, please contact:

Kirenaga Partners

Dave Scalzo

Managing Partner

(914) 202-6046

david.scalzo@kirenaga.com

Leighton Yenor

Marketing

(407) 575-3918

leighton.yenor@kirenaga.com

Violet Defense

Terrance Berland

Chief Executive Officer

(407) 433-1104 ext 1004

tberland@violetdefense.com

Jessica Jones

Marketing

(407) 433-1104 ext 1002

jjones@violetdefense.com

KIRENAGA OBSERVATIONS: Lyft Off?

Posted on: April 15th, 2019 by Kirenaga Partners

Two weeks ago, the ride-sharing company Lyft had its IPO – raising more than $2 billion with a $20+ billion market cap. Since then, Lyft’s stock price has declined by 16% while the overall market has risen.

But here’s the deal: investors who think Lyft has been a failure are Missing the Game. Quite simply, investment alpha is no longer being generated by the public markets. Rather, investment alpha is being generated and captured in the private markets, and those investors who fail to realize that the game has changed are suffering poor portfolio returns as a result.

In this newsletter, we dissect trends in the overall marketplace and the specifics of the Lyft transaction. We focus on who gets paid and the implications for individual investors and their investment portfolios.

Click on the link below and read away. We think you’ll enjoy it, and may even give some serious consideration to re-positioning your portfolio.

Kirenaga Observations: Lyft Off?

Yale Endowment Allocation to Venture Capital Approaches 20%

Posted on: March 11th, 2019 by Kirenaga Partners

The Yale endowment, one of the largest of its kind and pioneer of the alternative investment heavy strategy now so popular across the industry, has increased its allocation to venture capital to 19% as of June 2018. This continues a trend of increased emphasis on venture capital strategies. The allocation to venture capital has risen sharply from the 13.7% weighting seen in 2014.

Perhaps unsurprisingly, we share the endowment’s bullish assessment of venture capital as an asset class. Therefore, we hope this development encourages more investors to consider venture capital allocations for their portfolios.

Finally, you can read a Bloomberg News Network piece on the changes to the Yale portfolio at the link below.

Full Article